Abstract
Objectives
Basilar artery occlusion (BAO) may be etiologically attributed to embolism or in situ thrombosis due to basilar stenosis (BS). Patients with BAO due to BS (BAOS) are known to have worse outcomes than patients with embolic occlusions (BAOE). BAOS occurs more proximally in the basilar artery (BA) than BAOE. We hypothesize that differing brain stem infarct patterns contribute to outcome differences between these stroke etiologies.
Methods
This retrospective study includes 199 consecutive patients with BAO who received endovascular treatment at a single center. Final infarction in brain parenchyma dependent on the posterior circulation was graded semiquantitatively on magnetic resonance imaging (MRI). Associations to underlying stenosis and angiographic and clinical outcome variables were tested. The primary endpoint was early good clinical outcome (EGCO, mRS score ≤ 3 at discharge).
Results
Infarct extension of the medulla oblongata (OR = 0.25; 95% CI = 0.07–0.86; p = 0.03), the inferior pons (OR = 0.328; 95% CI = 0.17–0.63; p = 0.001), the superior pons (OR = 0.57; 95% CI = 0.33–0.99; p = 0.046), and the occipital lobes (OR = 0.46; 95% CI = 0.26–0.80; p = 0.006) negatively predicted EGCO. Infarct extension for other posterior-circulation-dependent brain regions was not independently associated with unfavorable early outcomes. Patients with BAOS had more proximal occlusions and greater infarct volumes in the inferior brain stem. Successful reperfusion (mTICI 2b-3) occurred more often in patients with BAOE than in BAOS (BAOE: 131 (96.3%); BAOS: 47 (83.9%), p = 0.005).
Conclusion
Unfavorable early outcomes in patients with BAOS may be explained by a higher likelihood of inferior brain stem infarcts and lower rates of reperfusion success.
Clinical relevance statement
Basilar artery occlusion due to underlying stenosis is associated with a poorer prognosis than that caused by embolism; these results suggest that aggressive endovascular therapy, usually involving the placement of a permanent stent, may be warranted in these patients.
Key Points
-
Inferior brain stem and occipital infarcts are prognostically unfavorable in basilar artery occlusion.
-
Basilar artery occlusion due to stenosis occurs more proximally and is associated with worse outcomes.
-
Differentiating etiologies of basilar artery occlusion may influence how aggressively treated the occlusion is.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Basilar artery occlusion (BAO) is considered a life-threatening emergency and is associated with high morbidity and mortality [1,2,3]. The etiology of most BAOs can be broadly divided into two categories: embolism and atherosclerosis. Other rare causes of BAO, which did not play a relevant role in this study, include basilar dissection or occlusions due to basilar aneurysms [4]. Embolism may be cardio-embolic or arterial-embolic, the latter being due to a vascular pathology like atherosclerosis or dissection of a proximally located arterial vessel. Atherosclerosis of the basilar artery (BA) causes basilar stenosis (BS) and may lead to local thrombus formation due to plaque rupture. BAO due to basilar stenosis (BAOS) occurs more proximally in the BA than BAO due to embolism (BAOE) [5,6,7].
BAOS has been associated with a worse outcome compared to BAOE [5,6,7]. However, the exact mechanism of the worst outcome remains unclear.
Brain stem infarcts are largely caused by occlusion of perforating arteries from the adjacently situated large vessels: the vertebral, basilar, or posterior cerebral arteries. Differences in prognostic outcomes may be due to differing patterns of brain stem infarcts; i.e., inferior brain stem infarcts in BAOS and superior brain stem infarcts in BAOE.
In this large single-center cohort at our comprehensive stroke center, we aimed to investigate the impact of infarct topography on clinical outcomes in patients with BAOS vs. BAOE. We hypothesized that worse outcome is mediated by infarcts of the inferior brainstem due to a more proximal occlusion location in patients with BAOS.
Materials and methods
Study population
This retrospective, single-center study included all consecutive patients who were admitted for ischemic stroke due to acute BAO at our comprehensive stroke center between March 2008 and June 2021 (n = 199). During the recruitment period, approximately 2800 patients received endovascular treatment for any type of ischemic stroke at our center. Patients with angiographically verified thromboembolic material in the BA who were referred for endovascular treatment were included in this study. Part of the patient cohort has been previously described [6, 8, 9]. For 144 out of the 199 patients, post-stroke magnetic resonance imaging (MRI) was available for ischemia grading. For all analyses not requiring MRI (grading of occlusion location and clinical and baseline clinical and outcome variables), we included all consecutive 199 patients to increase the generalizability of our findings. See Fig. S1, a flowchart of subject inclusion.
Ethical approval
Approval was obtained by the local ethics board in accordance with regional law under reference number 274/21 S-SR. Patient informed consent was waived by the ethics committee due to the retrospective nature of the study.
Clinical parameters
Clinical and imaging data were acquired retrospectively. Clinical, demographic, outcome, and procedural data of patients were gathered. National Institutes of Health Stroke Scale (NIHSS)-certified neurologists assessed the NIHSS score at the time of admission and discharge as part of the clinical routine. Substantial neurological improvement was defined as the difference between admission and discharge NIHSS score of ≤ 8 or discharge NIHSS score of ≤ 1 [6, 8, 10, 11]. NHISS improvement was calculated by subtracting the NHISS score at discharge from the score at admission. The modified Rankin Scale (mRS) score was used to measure disability at admission, at discharge (referred to as post-treatment in the text below), and after 3 months. An early good clinical outcome (EGCO) was defined as mRS score ≤ 3 at discharge. Due to missing follow-up patient data at 3 months (valid cases n = 83), discharge mRS was used as the primary endpoint.
The stroke etiology was classified according to the Trial of Org 10172 in Acute Stroke Treatment (TOAST) criteria [12]. Reperfusion success of endovascular therapy was quantified based on the modified Thrombolysis in Cerebral Infarction (mTICI) scale [13] by two independent neuroradiologists.
Grading of occlusion site, basilar stenosis, and infarct
All image-based grading was performed with the consensus of two experienced neuroradiologists.
After dividing the BA into thirds using digital subtraction angiography (DSA), the location of contrast agent discontinuation was used for grading: (1) proximal third beginning at the confluence, and including occlusions in the V4 segment with contralateral vertebral artery aplasia as previously described [6, 8]; (2) middle third, usually distal to the anterior inferior cerebellar artery; (3) distal third, the “basilar head”, see Fig. S2. Patients with V4 occlusions but without thrombotic material in the BA and without contralateral vertebral artery aplasia were not included in this study. Patients with proximal BAO may have had simultaneous V4 occlusions and patients with middle and distal BAO may have simultaneous posterior cerebral artery (PCA) occlusions.
BAOS was classified on peri-interventional DSA by detecting an underlying BS with vessel wall abnormalities and a trend to repeated thrombosis, excluding other reasons such as dissection. In three cases, classification was not possible due to failure of vessel reperfusion.
Infarct location was graded semiquantitatively on diffusion-weighted imaging (DWI). Infarct grading was performed for the following regions of interest (ROI), exactly matching the anatomical structure: the medulla oblongata, the inferior pons, the superior pons, the mesencephalon, the diencephalon, the cerebellum, and the perfusion territory of the PCA in the telencephalon, especially the occipital lobes. The inferior brain stem was defined as medulla oblongata and pons. The superior brain stem refers to the mesencephalon.
For each ROI, the following scores were distributed visually as described below based on the DWI-positive infarct volume as a percentage of the total ROI volume. The scoring was performed as a consensus reading of two expert raters (MRHP, 3 years of experience, and MB, 6 years of experience). An exemplary scoring in the superior pons can be found in Fig. S3.
0: 0% DWI volume, no infarct
1: 1–20% DWI volume, punctiform infarcts
2: 21–60% DWI volume, larger infarcts
3: 61–100% DWI volume, subtotal to total infarction
Statistical analysis
Variables with metric and ordinal data were described as the median and interquartile range (IQR). Categorical variables were described using absolute and relative frequencies.
Metric and ordinal data were compared using the Mann–Whitney-U-test when comparing two groups. Metric and ordinal data were compared using the Kruskal–Wallis test when comparing three or more groups. Pearson’s Chi-Square test was used to compare categorical variables. If categorical data was distributed on a 2 × 2 crosstab, Fisher’s exact test was used. p-values ≤ 0.05 were considered statistically significant.
To measure the impact of infarct extension in the ROIs on EGCO, a multivariate logistic regression model was calculated including the semiquantitative ischemia scores of all ROIs. To test the validity of this model to predict good clinical outcomes, ROC analyses were performed.
Univariate associations between baseline variables and EGCO were calculated. A multivariate logistic regression model using a stepwise forward variable selection method was calculated to predict EGCO of all variables that were significantly associated with ECOG in univariate analysis. ROC analyses were performed for this regression model.
Mediation models were calculated using the commonly available PROCESS extension for SPSS using a nonparametric bootstrap approach with 5000 replication samples to obtain a 95% CI [14, 15].
Results
Baseline characteristics, clinical, and angiographic outcomes
This study includes 199 patients with BAO. The median age of patients included in this study was 75 years (IQR = 63–82) and 115 (58%) were male. In n = 3, no etiological classification was feasible on DSA. Of the rest (n = 196), 139 (71%) had no underlying BS, and 57 (29%) had an underlying BS.
BAOS was significantly more likely to occur in the proximal BA than BAOE, p < 0.001 (Fig. 1). Patients with BAOS showed significantly higher post-treatment disability compared to patients with BAOE (median mRS = 5, IQR = 4–6 in the BAOS group; median mRS = 4, IQR = 2–5 in the BAOE group; p = 0.001). Similarly, significantly higher post-treatment disability was observed in patients with more proximal occlusion (proximal third median mRS = 5, IQR = 4–6; middle third median mRS = 4.5, IQR = 3–5.75; and distal third median mRS = 4, IQR = 1–5; p = 0.008). There was a non-significant tendency toward a better outcome in patients with more distal occlusions when considering only patients with BAOE (Fig. S4A) and only BAOS (Fig. S4B). Failure to reach statistical significance in these analyses is likely due to too few cases of proximal occlusion in BAOE and distal occlusion in BAOS. Rates of complete reperfusion (mTICI 3) and successful reperfusion (mTICI 2b or higher) were significantly lower in patients with BAOS (mTICI 3 = 99 (72.8%) in BAOE and 32 (57.1%) in BAOS, p = 0.04; mTICI 2b or higher = 131 (96.3%) in BAOE and 47 (83.9%) in BAOS, p = 0.005). However, after excluding patients who did not undergo stenting of the BA (n = 12), there was no significant difference in TICI scores between patients with BAOS vs. BAOE. Table 1 gives an overview of the baseline and outcome characteristics of all patients and patients divided into groups based on stroke etiology (BAOS vs. BAOE) and location of BAO in BA thirds.
Effect of BS and occlusion location on ischemic territory
Of all included patients, 144 patients (72%) received a post-stroke MRI adequate for the characterization of ischemic territory. Semiquantitative volumetric analysis of DWI-positive ischemic territory was performed as described above. Figure 2A shows the likelihood of ischemia scores ≥ 2 for each ROI in all patients. Ischemia grading revealed significantly greater ischemia likelihood in the medulla oblongata and the pons in patients with BAOS in comparison to patients with BAOE (e.g.: ischemia score ≥ 2 in the medulla: 2.1% in BAOE and 13.0% in BAOS; p < 0.001) (Fig. 2B). No significant difference was observed in ischemia scores of the remaining ROIs, however, ischemia likelihood of the mesencephalon and diencephalon were tendentially greater in BOAE.
After dividing cases based on occlusion location, proximal occlusion showed peak ischemia likelihood in the inferior pons, whereas ischemia likelihood peaked in the mesencephalon and diencephalon in patients with distal occlusions, see Fig. 2C. There was higher ischemia likelihood in the cerebellum in patients with proximal and distal BA occlusions compared to patients with occlusions in the middle BA third.
Impact of ischemic pattern on early clinical outcome
Only ischemia scores of the medulla oblongata (OR = 0.25; 95% CI = 0.07–0.86; p = 0.03), the inferior pons (OR = 0.328; 95% CI = 0.17–0.63; p = 0.001), the superior pons (OR = 0.57; 95% CI = 0.33–0.99; p = 0.046), and the occipital lobes (OR = 0.46; 95% CI = 0.26–0.80; p = 0.006) were independently negatively associated with EGCO. Ischemia scores in the mesencephalon, the diencephalon, and the cerebellum did not independently predict EGCO (Fig. 3). For a ROC analysis of this regression model, see Fig. S5A.
Impact of baseline data on early clinical outcome
Primary, univariate non-adjusted analyses were performed for various variables to test their association with EGCO. Factors such as age, occlusion site, underlying BS, diabetes as a risk factor, complete recanalization (TICI 3), and procedure time were significantly associated with EGCO, see Table S1.
The variables age (OR = 0.96; 95% CI = 0.94–0.99; p = 0.005), occlusion location (OR = 1.86; 95% CI = 1.17–2.96; p = 0.009), diabetes (OR = 0.13; 95% CI = 0.04–0.45; p = 0.002), and procedure time (OR = 0.98; 95% CI = 0.98–0.99; p = 0.008) were independently associated with EGCO, see Table 2. A ROC curve of this regression study is found in Fig. S5B.
Excluding procedure time due to collinearity with mTICI as well as with BAOS and excluding occlusion location due to collinearity with BAOS from multivariate analyses, complete reperfusion (mTICI 3) (OR = 2.24, 95% CI = 1.05–4.78), and BAOS (OR = 0.30, 95% CI = 0.13–0.68) showed a significant association to EGCO, see Table S2. A ROC curve of this regression study is found in Fig. S5C.
Role of ischemic pattern for outcome in BAO with BS
A mediation model with BS as the causal (independent) variable, post-treatment mRS as the outcome (dependent) variable, and the semivolumetric infarction scores for all investigated brain areas, as mediator variables were calculated. The total effect of BS on post-treatment mRS was 1.3 (95% CI = 0.58–2.03, p < 0.001). The bootstrapped 95% CI for the indirect effect was different from zero, indicating the infarct distribution mediates the relationship between BS and clinical outcome. The indirect effect of ischemic extension on the outcome considering the ischemia scores for all ROIs was 1.0 (95% CI = 0.46–1.64), whereas amongst all ROIs, only ischemia of the medulla oblongata (effect = 0.31, 95% CI = 0.08–0.60), the inferior pons (effect = 0.61, 95% CI = 0.22–1.08), and the superior pons (effect = 0.27, 95% CI = 0.04–0.61) individually significantly mediated the effect of BS on outcome, see Table S3. The direct effect of BS on mRS lost statistical significance (direct effect: 0.27; CI: –0.39–0.93; p = 0.41) (Fig. 4).
Discussion
This large, single-center study including 199 patients treated for BAO between 2008 and 2021 yields two main results: firstly, the early outcome in patients with BAO is dependent on the degree of infraction of the inferior brain stem and the occipital lobes. This finding partly explains a worse outcome in BAOS, where more proximal occlusions lead to inferior brain stem infarcts. Second, a worse prognosis of BAOS is also partly due to diminished angiographic outcome.
Functional eloquence of brain stem tissue
The brain stem acts as a crucial conduit for major ascending and descending fiber tracts governing motor, sensory, and vegetative functions. It houses nuclei of cranial nerves and circuits for central respiratory and circulation control, compressing numerous vital neuroanatomical structures into a compact space. Even small, punctiform brain stem infarcts can result in significant neurological deficits. The functional eloquence of brain stem tissue elucidates the unfavorable outcomes observed in BAO, irrespective of its etiology. In this study, we use regression analysis to show ischemia in the medulla oblongata and pons as well as ischemia in the territory of the PCA in the telencephalon independently predicting bad early outcomes. Ischemia in the mesencephalon and diencephalon did not independently predict early outcomes. The brain stem receives its blood supply largely from small perforating arteries stemming directly from the BA. We show that occlusion of the proximal BA leads to inferior brain stem infarcts whereas thrombosis of the basilar apex predisposes to infarcts of the superior brain stem like the mesencephalon and thalamus. This is consistent with perforator ischemia at the location of the thrombus with little potential for collateral flow, causing adjacent tissue infarction.
In the context of BAO, where infarct patterns are complex and usually include more than one anatomical brain stem region, we show that the overall drivers of outcome are infarct volumes in the inferior brain stem (pons and medulla oblongata) as opposed to the mesencephalon and thalamus. The downward shift of maximum infarct extension and likelihood in the brain stem, as shown in this study, from superior (mesencephalon, diencephalon in embolic occlusions) to inferior (pons, medulla oblongata in stenotic occlusions), therefore, likely partially explains the differences in outcome observed between the two groups.
Patients with isolated superior brain stem infarcts may also suffer from disastrous outcomes, even without concomitant infarcts in the inferior brain stem, this has been well-documented in literature [16, 17] and is frequently observed in clinical routine. However, considering the overall infarct pattern within BAO, a shift from the superior to the inferior brain stem is prognostically unfavorable, a motif that was seen in the entire cohort and as a tendency for both the embolic and stenotic subgroups individually.
Infarcts in the occipital lobes also predicted worse early outcomes in regression analysis. This is possibly due to a risk of tissue swelling and mass effect-related complications in this comparatively large area of vascular territory. In a mediation analysis, we show that infarct distribution significantly mediates the relationship between BS and outcome. Similar to the regression analysis, mediation analysis showed significant mediation of BS on mRS only for ischemic volumes in the medulla oblongata and pons.
Worse angiographic outcome in patients with basilar stenosis
We showed that patients with BAOS had significantly worse angiographic outcomes as measured by mTICI than patients with BAOE. After excluding procedure time and occlusion location due to collinearity with reperfusion success and presence of BS, respectively; both reperfusion success and presence of BS were significantly associated with outcome in multivariate analysis.
However, excluding patients who did not receive stenting in the BAOS group (n = 12), no differences in angiographic outcome were observed between patients with BAOS and patients with BAOE.
Implications
In the BASILAR registry study, as well as the recently published ATTENTION and BAOCHE trials, patients with proximal occlusions profited more from interventional treatment than patients with mid- or distal occlusions [18,19,20]. These findings are likely due to a higher incidence of stenotic occlusions in the proximal BA third, where medical therapy including intravenous thrombolysis has little therapeutic effect. However, the presence or absence of underlying stenosis was not explicitly recorded in these studies.
Due to differences in stroke mechanism and etiology, BAOS should be treated as an entirely different disease entity. Stenotic occlusions, with their propensity to cause inferior brain stem infarcts and overall diminished angiographic outcome, should be afforded aggressive interventional therapy with a low threshold to perform stenting if re-occlusion is deemed likely. Previous studies have aimed to identify a patient’s stenotic BAO using admission CT data, facilitating pre-intervention workflows like planning for a longer procedure time, possible stenting, and antithrombotic therapy [6, 9]. Further studies are required to establish appropriate treatment approaches for patients with stenotic BAO and prospective studies that are conducted in the future should track and analyze the sub-population of BAOS to determine their impact on overall trial outcome.
Limitations
This study is limited by its retrospective and single-center design. Not all patients with BAO included in this study later received MRI in a clinical routine that was required for visual analysis, possibly leading to a slight selection bias. Follow-up data was limited in this patient cohort, mRS after three months was not sufficiently available to use as a primary end-point. MRS at hospital discharge was used alternatively in this study, possibly limiting the comparability of results to other studies. The use of mTICI classification may be another limitation as it is limited in its classification of residual side branch occlusion after BAO. As this is particularly relevant for ischemic patterns, it should be the focus of further studies.
Conclusion
In BAO, infarct extension in the inferior brain stem (medulla oblongata/pons) and the occipital lobes determine the overall outcome. The functional eloquence of the inferior brain stem partially explains reduced outcome in BAOS, where occlusions occur more proximally in comparison to BAOE. Moreover, the angiographic result, assessed through mTICI, is compromised in individuals with BAOS, particularly among those who do not undergo stenting, leading to a further decline in clinical outcome.
Abbreviations
- BA:
-
Basilar artery
- BAO:
-
Basilar artery occlusion
- BAOE:
-
Basilar artery occlusion due to embolism
- BAOS:
-
Basilar artery occlusion due to basilar stenosis
- BS:
-
Basilar stenosis
- DSA:
-
Digital subtraction angiography
- DWI:
-
Diffusion-weighted imaging
- EGCO:
-
Early good clinical outcome, mRS at discharge ≤ 3
- IQR:
-
Interquartile range
- MRI:
-
Magnetic resonance imaging
- mRS:
-
Modified Rankin Scale
- mTICI:
-
Modified treatment in cerebral infarction
- NIHSS:
-
National Institutes of Health Stroke Scale
- PCA:
-
Posterior cerebral artery
References
Sheng K, Tong M (2019) Therapy for acute basilar artery occlusion: a systematic review and meta-analysis. F1000Res 8:165
Smith WS (2007) Intra-arterial thrombolytic therapy for acute basilar occlusion: pro. Stroke 38:701–703
Sparaco M, Ciolli L, Zini A (2019) Posterior circulation ischaemic stroke-a review part I: anatomy, aetiology and clinical presentations. Neurol Sci 40:1995–2006
Beer-Furlan A, Dasenbrock HH, Joshi KC, Chen M (2019) Endovascular management of basilar artery occlusion secondary to fusiform aneurysm with intraluminal thrombus. Neurosurg Focus 46:V2
Baik SH, Park HJ, Kim JH, Jang CK, Kim BM, Kim DJ (2019) Mechanical thrombectomy in subtypes of basilar artery occlusion: relationship to recanalization rate and clinical outcome. Radiology 291:730–737
Berndt MT, Pree D, Kaesmacher J et al (2020) From perviousness to plaque imaging in acute basilar occlusions: the impact of underlying stenosis and how to detect it. Stroke 51:766–774
Kim YW, Hong JM, Park DG et al (2016) Effect of intracranial atherosclerotic disease on endovascular treatment for patients with acute vertebrobasilar occlusion. AJNR Am J Neuroradiol 37:2072–2078
Boeckh-Behrens T, Pree D, Lummel N et al (2019) Vertebral artery patency and thrombectomy in basilar artery occlusions. Stroke 50:389–395
Mueck F, Hernandez Petzsche M, Boeckh-Behrens T et al (2022) CT marker in emergency imaging of acute basilar artery occlusion: thrombosis vs. embolism. Diagnostics 12:1817
Kerr DM, Fulton RL, Lees KR, Collaborators V (2012) Seven-day NIHSS is a sensitive outcome measure for exploratory clinical trials in acute stroke: evidence from the Virtual International Stroke Trials Archive. Stroke 43:1401–1403
Young FB, Weir CJ, Lees KR, Committee GITS, Investigators (2005) Comparison of the National Institutes of Health Stroke Scale with disability outcome measures in acute stroke trials. Stroke 36:2187–2192
Adams Jr. HP, Bendixen BH, Kappelle LJ et al (1993) Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 24:35–41
Zaidat OO, Yoo AJ, Khatri P et al (2013) Recommendations on angiographic revascularization grading standards for acute ischemic stroke: a consensus statement. Stroke 44:2650–2663
Hayes AF, Rockwood NJ (2017) Regression-based statistical mediation and moderation analysis in clinical research: observations, recommendations, and implementation. Behav Res Ther 98:39–57
Preacher KJ, Hayes AF (2004) SPSS and SAS procedures for estimating indirect effects in simple mediation models. Behav Res Methods Instrum Comput 36:717–731
Barkhof F, Valk J (1988) “Top of the basilar” syndrome: a comparison of clinical and MR findings. Neuroradiology 30:293–298
Ahn SH, Kim BJ, Kim YJ, Kang DW, Kwon SU, Kim JS (2018) Patterns and outcomes of the top of the basilar artery syndrome: the role of the posterior communicating artery. Cerebrovasc Dis 46:108–117
Jovin TG, Li C, Wu L et al (2022) Trial of thrombectomy 6 to 24 h after stroke due to basilar-artery occlusion. N Engl J Med 387:1373–1384
Tao C, Nogueira RG, Zhu Y et al (2022) Trial of endovascular treatment of acute basilar-artery occlusion. N Engl J Med 387:1361–1372
Writing Group for the BG, Zi W, Qiu Z et al (2020) Assessment of endovascular treatment for acute basilar artery occlusion via a Nationwide Prospective Registry. JAMA Neurol 77:561–573
Funding
This work is supported by a KKF grant from the Technical University of Munich to MRHP. Open Access funding enabled and organized by Projekt DEAL.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Guarantor
The scientific guarantor of this publication is Maria Berndt.
Conflict of interest
The authors of this manuscript declare no relevant relationships.
Statistics and biometry
One of the authors has significant statistical expertise.
Informed consent
Written informed consent was waived by the Institutional Review Board.
Ethical approval
The Institutional Review Board approval of the TUM University Hospital was obtained.
Study subjects or cohorts overlap
Some study subjects or cohorts have been previously reported in Berndt et al [6], Boeckh-Behrens et al [8], Mueck et al [9].
Methodology
-
Retrospective
-
Observational
-
Single center study
Additional information
Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Hernandez Petzsche, M.R., Maegerlein, C., Wunderlich, S. et al. Impact of ischemic stroke topography on early clinical outcome of basilar artery occlusion: a retrospective study. Eur Radiol (2024). https://doi.org/10.1007/s00330-024-10755-y
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00330-024-10755-y